NervGen to Enroll 2nd Volunteer Group in NVG-291 Trial & The Invisible Symptoms of MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291 was deemed well tolerated, and is allowing enrolment of a second group of volunteers into its clinical trial.
He also reads “The Visible and Invisible Reflections of MS”, from Beth Ullah's column "Through the Looking Glass".

===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/